Luca Roncati

31PUBLICATIONS
7CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Software quality, processes and metricsVirtual and mixed realityHealth promotion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Sep 27, 2025
pDNA Impurities in mRNA Vaccines.

Luca Roncati, Nazha Ghaleb, Joya Ghaleb

|Apr 26, 2025
Adjuvant Metronomic Chemotherapy After Surgery in pT1-T2 N0 M0 HER2-Positive and ER/PR-Positive Breast Cancer Plus Targeted Therapy, Anti-Hormonal Therapy, and Radiotherapy, with or Without Immunotherapy: A New Operational Proposal.

Luca Roncati

|Feb 13, 2025
Ozone-Oxygen Therapy to Prevent HPV-Related Cancers of the Lower Gynecological Tract in Infected Patients: The Rationale for Further Developments.

Luca Roncati

|Mar 28, 2024
A Real-World Nationwide Study on COVID-19 Trend in Italy during the Autumn-Winter Season of 2020 (before Mass Vaccination) and 2021 (after Mass Vaccination) Integrated with a Retrospective Analysis of the Mortality Burden per Year.

Luca Roncati, Carlo Galeazzi, Giulia Bartolacelli

|Dec 22, 2023
Trends in the COVID-19 Pandemic in Italy during the Summers of 2020 (before Mass Vaccination), 2021 (after Primary Mass Vaccination) and 2022 (after Booster Mass Vaccination): A Real-World Nationwide Study Based on a Population of 58.85 Million People.

Luca Roncati, Giulia Bartolacelli, Carlo Galeazzi

|Sep 28, 2023
SARS-CoV-2 Induced Herpes Virus Reactivations and Related Implications in Oncohematology: When Lymphocytopenia Sets in and Immunosurveillance Drops Out.

Luca Roncati, Elizabeth Sweidan, Cyrielle Tchawa

Pageof 6

Frequent Collaborators

1 joint publications

Beniamino Palmieri

1 joint publications

Vincenzo Nasillo

1 joint publications

Giovanni Riva

1 joint publications

Andrea Messerotti